Danaher Says AB Sciex Integration Going 'Very Well,' Hints of Launches at ASMS

Danaher did not break out mass spec sales figures for its first-quarter earnings results today, but CEO Larry Culp said, "We've been very pleased with the customer and associate feedback that we've received to date."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.